Global organ transplant immunosuppressant market 2017-2021


◆タイトル:Global organ transplant immunosuppressant market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥371,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About Organ Transplant ImmunosuppressantAn organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.

Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Novartis,
• Astellas Pharma,
• Pfizer,
• Sanofi,

[Other prominent vendors]
• AbbVie
• Bristol-Myers Squibb
• F. Hoffmann-La Roche

[Market driver]
• Increased incidence of organ failure
• For a full, detailed list, view our report

[Market challenge]
• Insufficient organ supply
• For a full, detailed list, view our report

[Market trend]
• Growing trend of medical tourism
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Introduction to organ transplantation
• What is an organ transplantation?
• How common is organ transplantation?
• Increasing trend of organ transplantation
• Need for immunosuppression during organ transplant
• What is an immunosuppressant?
• Role of an immunosuppressant during organ transplant

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Key clinical trials

PART 08: Market segmentation by drug class
• Selective inhibitor of cytokine production and function
• Immunosuppressive antimetabolites
• Immunosuppressive antibodies
• Immunosuppressive adrenocorticosteroids

PART 09: Market segmentation by therapeutic application
• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation
• Other transplantation

PART 10: Geographical segmentation
• Organ transplant immunosuppressant market in Americas
• Organ transplant immunosuppressant market in EMEA
• Organ transplant immunosuppressant market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Market challenges

PART 13: Market trends
• Growing trend of medical tourism
• New government initiatives on transplant research programs
• Growing focus toward the use of biologics

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• Astellas Pharma
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors

PART 16: Appendix
• List of abbreviations


Novartis, Astellas Pharma, Pfizer, Sanofi,AbbVie, Bristol-Myers Squibb, and F. Hoffmann-La Roche.





★調査レポート[臓器移植用免疫抑制薬の世界市場2017-2021] (Global organ transplant immunosuppressant market 2017-2021 / IRTNTR13495)販売に関する免責事項
[臓器移植用免疫抑制薬の世界市場2017-2021] (Global organ transplant immunosuppressant market 2017-2021 / IRTNTR13495)についてEメールでお問い合わせ